President of the Management Board of NANOGROUP S.A.

Associated with the health market since 2004. As Managing Director, he restructured and developed the most dynamically operating Medical Center in the Podkarpacie region, creating and setting new standards of customer service quality on the market. Co-creator of the first solution in Poland for online registration of medical appointments. Co-founder of the first and only Infertility Treatment Clinic (MEDICOR) in Podkarpacie, which he headed as the President until 2009. He was responsible for the development of health insurance in the PZU Group. As Vice President of PZU Pomoc S.A. created the largest medical TPA in Poland to handle health insurance. Co-founder of the first drug insurance in Poland. Since 2015, he has been active in the field of Wealth Management and advises on management and finance. A graduate of International Economic and Political Relations as well as Management and Marketing at the Warsaw School of Economics.

Vice President of the Management Board of NANOGROUP S.A.

Clinical pharmacology specialist, former advisor to the Minister of Health on drug policy. He negotiated Poland’s accession to the EU in the field of pharmacy, responsible for the implementation of EU directives in the field of pharmacy into the Polish legal system. Co-founder of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products. Owner of a consulting company cooperating with international pharmaceutical companies in the field of introducing new technologies to the Polish market.

Executive Director of NANOGROUP S.A.

For almost 30 years he has been involved in research and consulting in the health market. His professional experience includes many years of managing the Polish branch and the Central European region at IMS Health (IQVIA) and managing research and consulting companies Azyx, Sequence HC Partners and PEX PharmaSequence. He is the author of a number of presentations at many conferences in Poland and abroad as well as publications in the general and professional press on the Polish health market, and the drug market in particular.

President of the Supervisory Board of NANOGROUP S.A.

Medical doctor, also completed MBA, effective manager. Organizer of the business model and company structures – experienced in building and developing companies and conducting enterprise restructuring processes. In the past, director and motivator of large companies and teams of people. A recognizable man as a leader in the Polish pharmaceutical industry. Member of the Supervisory Board of American Heart of Poland SA and President of WSiP SA. Previously, the President of Astra Zeneca Sp. z o.o., President of Fournier Polska Sp. z o.o., Sales Director at Pfizer Polska Sp. z o.o., Sales Director and Marketing Director of MSD Poland – also active in the field of clinical trials.

Well-known investor focused on medical and biotech companies. He has extensive professional experience related to the healthcare sector. Founder of Prosper S.A., who has been a member of NEUCA S.A. – the leader in the pharmaceutical distribution market in Poland. Member of supervisory boards listed on the Warsaw Stock Exchange of NEUCA, Selvita and Braster. He is also involved in venture capital funds: Inovo and Experior. Doctor of Technical Sciences, graduate of Warsaw University of Technology.

Member of the Supervisory Board of NANOGROUP S.A.

Co-founder of Top Consulting SA, one of the oldest consulting companies on the Polish market. He has over 25 years of international experience in the field of investment consulting, raising capital for companies, market acquisitions and company management. A longtime consultant of American financial organizations on Wall Street in New York, including those listed on the NASDAQ and NYSE stock exchanges. He advised, among others: Household International in the preparation of a takeover strategy and obtaining a banking license in Poland, Wussler Group, partner of Ted Turner Pictures in an attempt to take over NTV, the largest private TV station in Russia, Eiffage Construction in the acquisition of Mitex, the largest at that time, construction company, the Industrial Union of Donbass, an industrial group in Ukraine. Member, chairman and chairman of supervisory boards of many companies listed on the Warsaw Stock Exchange, including: Bauma SA (now ULMA SA), Computerland Poland SA (now Signity), PolAqua SA Co-founder of the Start-up Hub Poland Fund. A graduate of the Faculty of Journalism and Political Science at the University of Warsaw and International Relations at the University of Hawaii in Honolulu.

Member of the Supervisory Board of NANOGROUP S.A.

For many years, the President of the Management Board of NanoGroup, a holding of biotechnology companies. Entrepreneur, manager and founder of many innovative companies with over 20 years of experience as a co-owner and board member in leading Polish biotechnology, IT and e-commerce companies. After more than a decade of work as the president of the first internet portal in Poland – Wirtualna Polska, he founded the Polish-Israeli VC Giza Polish Ventures. Founder of the Sobieski Institute think-tank, the Startup Hub Poland Foundation. Member of supervisory boards in many innovative companies. Marek is a graduate of the Faculty of Management and Economics of the Gdańsk University of Technology, he also studied at the University of Wales in Great Britain. He conducted research at the Nuclear Research Center in Karlsruhe and the Gdańsk University of Technology.

Co-founder of NanoThea S.A.

Deeply focused in nanomedical devices for drug delivery and diagnostics dedicated to oncological applications. First gained her experience in R&D team at NanoVelos (targeted chemotherapy) company, then nominated for CEO of NanoThea (radiopharmaceuticals for early diagnostics). Doing her PhD and MBA studies to combine science with bussines world and commercialisation of life-science projects. Leads the team and spreads her passion for the idea of nanoparticles. Her competences join leadership and technological issues of nanoparticles manufacturing.

Founder of NanoVelos S.A.

PHD in Biomedical Engineering in Industrial Biotechnology at the Warsaw University of Technology, Faculty of Chemistry. Co-author of the patent “A method for preparing polysaccharide nanoparticles”, the basis of NanoVelos technology. Her 8 year laboratory experience began with receiving microcapsules for chondrocytes encapsulation in cartilage regeneration. Has experience in the synthesis of polymer nanoparticles as well as metals, obtained by chemical synthesis or in microfluidic systems. Completed numerous trainings, including Nanotechnology Summer School at University of Oxford. Worked as scientist in several grants. Cooperation during European grant FonDiag (EuroNanoMed) results in scholarship at Institute of Advanced Technology for Life Sciences (ITAV) in France.

NANOGROUP S.A.
ul. Rakowiecka 36
02-532 Warszawa
+48604741303
TAX: 5213757847